Foslip

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2017
01220072017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Current osteosarcoma therapies cause severe treatment-related side effects and chemoresistance, and have low success rates… (More)
Is this relevant?
2015
2015
BACKGROUND Inflammatory bowel diseases are incurable illnesses of the gastrointestinal tract, which substantially enhance the… (More)
Is this relevant?
2014
2014
BACKGROUND AND OBJECTIVE Photodynamic therapy (PDT) with photosensitizers that locate in endocytic vesicles of cancer cells can… (More)
Is this relevant?
2011
2011
BACKGROUND AND OBJECTIVE Foslip® and Fospeg® are liposomal formulations of the photosensitizer mTHPC, intended for use in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4–8
  • figure 4
Is this relevant?
2010
2010
As previously described, Fluorescence differential path length spectroscopy (FPDS) can determine chromophore concentrations non… (More)
Is this relevant?
2009
2009
Liposomal formulations of meso-tetra(hydroxyphenyl)chlorin (mTHPC) have already been proposed with the aim to optimize… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Foslip is a recently designed third generation photosensitiser based on unilamellar dipalmitoylphosphatidylcholine… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
2008
2008
A fluorescence microscope equipped with a condenser for total internal reflection (TIR) illumination was combined with a pulsed… (More)
Is this relevant?
2008
2008
BACKGROUND AND OBJECTIVES Generalized skin sensitization is a main drawback of photodynamic therapy with systemic administration… (More)
Is this relevant?
2007
2007
Due to the poor prognosis and limited management options for perihilar cholangiocarcinoma (CC) the development of alternatives… (More)
Is this relevant?